|

CD33 FPBMC Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • University of Virginia1

Indications

  • Myelodysplastic/Myeloproliferative Neoplasm1
  • Acute Myeloid Leukemia1
  • Myelodysplastic Syndromes1
  • Cancer1

Charlottesville, Virginia1 trial

Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS

University of Virginia

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.